valsartan has been researched along with Cerebral Ischemia in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, J; Wang, CQ; Wang, Y; Zhang, JF | 1 |
| Jaggi, AS; Kaur, S; Kumar, K; Singh, N | 1 |
| Lee, YB; Shin, DH; Song, S | 1 |
| Fujita, T; Horiuchi, M; Iwai, M; Iwanami, J; Li, JM; Min, LJ; Mogi, M; Sakata, A; Tsukuda, K | 2 |
| Furuno, M; Higaki, J; Horiuchi, M; Inaba, S; Iwai, M; Kanno, H; Mogi, M; Okayama, H; Senba, I; Tomono, Y | 1 |
| Kato, T; Kinouchi, H; Wakai, T; Yagi, T; Yoshioka, H | 1 |
| Chen, R; Hata, R; Horiuchi, M; Ide, A; Iwai, M; Liu, HW; Okamoto, S; Sakanaka, M; Shiuchi, T | 1 |
| Horiuchi, M; Iwai, M; Iwanami, J; Li, JM; Min, LJ; Mogi, M; Tsukuda, K | 1 |
1 trial(s) available for valsartan and Cerebral Ischemia
| Article | Year |
|---|---|
Comparison of the Effect of Fimasartan versus Valsartan on Blood Pressure Variability in Acute Ischemic Stroke: A Double-Blind Randomized Trial.
Topics: Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Blood Pressure; Brain Ischemia; Double-Blind Method; Humans; Prospective Studies; Pyrimidines; Republic of Korea; Stroke; Tetrazoles; Time Factors; Treatment Outcome; Valsartan | 2019 |
8 other study(ies) available for valsartan and Cerebral Ischemia
| Article | Year |
|---|---|
The initial timing and dosage pattern of sacubitril/valsartan in patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Angiotensin Receptor Antagonists; Biphenyl Compounds; Brain Ischemia; Drug Combinations; Heart Failure; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Prospective Studies; Stroke; Stroke Volume; Tetrazoles; Treatment Outcome; Valsartan; Ventricular Function, Left | 2023 |
Valsartan Protects in High Fat Diet During Ischemic Reperfusion Injury.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Brain Ischemia; Cerebral Infarction; Cholesterol; Diet, High-Fat; Memory Disorders; Neuroprotective Agents; Nitrites; Rats; Rats, Wistar; Reperfusion Injury; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha; Valsartan | 2023 |
Deletion of angiotensin II type 2 receptor attenuates protective effects of bone marrow stromal cell treatment on ischemia-reperfusion brain injury in mice.
Topics: Animals; Antihypertensive Agents; Bone Marrow Transplantation; Brain Infarction; Brain Ischemia; Cells, Cultured; Chemokine CCL2; Disease Models, Animal; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reperfusion Injury; Stromal Cells; Survival Rate; Tetrazoles; Treatment Outcome; Tumor Necrosis Factor-alpha; Valine; Valsartan | 2008 |
Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Brain Chemistry; Brain Ischemia; Capillaries; Cerebrovascular Circulation; Humans; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Transgenic; Oxidative Stress; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Reverse Transcriptase Polymerase Chain Reaction; Superoxides; Tetrazoles; Valine; Valsartan | 2009 |
Effects of valsartan on neuroprotection and neurogenesis after ischemia.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Blotting, Western; Brain Ischemia; Immunohistochemistry; In Situ Nick-End Labeling; Male; Neurogenesis; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Tetrazoles; Valine; Valsartan | 2011 |
Possible inhibition of focal cerebral ischemia by angiotensin II type 2 receptor stimulation.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Brain Chemistry; Brain Ischemia; Cerebrovascular Circulation; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NADPH Oxidases; Oxidative Stress; Receptor, Angiotensin, Type 2; Superoxides; Tetrazoles; Valine; Valsartan | 2004 |
Angiotensin II type-2 receptor stimulation prevents neural damage by transcriptional activation of methyl methanesulfonate sensitive 2.
Topics: Angiotensin II; Animals; Brain Ischemia; Cell Differentiation; Cells, Cultured; Cognition; Mice; Mice, Inbred C57BL; Neurons; Receptor, Angiotensin, Type 2; RNA, Messenger; RNA, Small Interfering; Signal Transduction; Tetrazoles; Transcriptional Activation; Ubiquitin-Conjugating Enzymes; Valine; Valsartan | 2006 |
Temporary pretreatment with the angiotensin II type 1 receptor blocker, valsartan, prevents ischemic brain damage through an increase in capillary density.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Brain; Brain Injuries; Brain Ischemia; Capillaries; Chemokine CCL2; DNA Damage; Infarction, Middle Cerebral Artery; Mice; Mice, Inbred C57BL; Oxidative Stress; Receptor, Angiotensin, Type 1; Superoxides; Tetrazoles; Valine; Valsartan | 2008 |